NCT03249311 - Levomilnacipran in Healthy Males | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 2, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

May 1, 2022

Conditions

None (i.e. Healthy Volunteers)

Interventions

DRUG

Levomilnacipran

Escalating doses of 40 to 120mg/day every 7 days (+/- 1 day) throughout a 20-26 day period.

DRUG

Duloxetine

Escalating doses of 40 to 120mg/day every 7 days (+/- 1 day) throughout a 20-26 day period.

DRUG

Placebos

Escalating doses of 40 to 120mg/day every 7 days (+/- 1 day) throughout a 20-26 day period.

Trial Locations (1)

Institute of Mental Health Research, Royal Ottawa Mental Health Centre, Ottawa